Trials / Completed
CompletedNCT03269045
Study of ORL-1B in Patients With Biotinidase Deficiency
An Open-label, Single-arm, Phase 2 Study of ORL-1B in Patients With Biotinidase Deficiency
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Orpha Labs · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An Open-label, Single-arm, Phase 2 Study of Biotin in Patients With Biotinidase Deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ORL-1B | Oral ORL-1B |
Timeline
- Start date
- 2013-08-31
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2017-08-31
- Last updated
- 2018-01-17
Source: ClinicalTrials.gov record NCT03269045. Inclusion in this directory is not an endorsement.